1 Introduction Prostate cancer (PCa) is one of the most common malignancies in men, with both incidence and mortality rates continuing to rise globally [1, 2]. Although early-stage PCa generally has a favourable prognosis and can be effectively managed through surgery, radiotherapy and hormone therapy, the treatment of advanced and castration-resistant prostate cancer (CRPC) remains a major clinical challenge [3, 4].
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile
Get in touch with Qinquan
Contact Qinquan, search articles and posts on X, monitor coverage, and track replies from one place.
Learn more about Muck Rack